In this week's edition...
​
— CMS Public Engagement Events for Medicare Drug Negotiation Program. See details below.
— ICHOM Conference and Activities Geared Up for 2025. See details below.
— QALY Impact in Canada: Local Family Struggled to Find Treatment, Financing for Rare Disease. Click here to read more.
— Use of QALYs and Similar Measures Deemed Acceptable in MD, Considered in Congress. See details below.
— The Protecting Health Care for All Patients Act Has No Budget Impact. See details below.
— CMS References ICER and NICE in Explanations for Medicare Drug Price Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— PCORI Engagement Award Letters of Intent Due April 1! See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below

In this week's edition...
 
— CMS Public Engagement Events for Medicare Drug Negotiation Program. See details below.
— ICHOM Conference and Activities Geared Up for 2025. See details below.
— QALY Impact in Canada: Local Family Struggled to Find Treatment, Financing for Rate Disease. Click here to read more.
— Use of QALYs and Similar Measures Deemed Acceptable in MD, Considered in Congress. See details below.
— The Protecting Health Care for All Patients Act Has No Budget Impact. See details below.
— CMS References ICER and NICE in Explanations for Medicare Drug Price Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— PCORI Engagement Award Letters of Intent Due April 1! See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below

In this week's edition...
 
— CMS Public Engagement Events for Medicare Drug Negotiation Program. See details below.
— Use of QALYs and Similar Measures Deemed Acceptable in MD, Considered in Congress. See details below.
— The Protecting Health Care for All Patients Act Has No Budget Impact. See details below.
— CMS References ICER and NICE in Explanations for Medicare Drug Price Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— PCORI Engagement Award Letters of Intent Due April 1! See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— CMS Public Engagement Events for Medicare Drug Negotiation Program. See details below.
— Use of QALYs and Similar Measures Deemed Acceptable in MD, Considered in Congress. See details below.
— The Protecting Health Care for All Patients Act Has No Budget Impact. See details below.
— CMS References ICER and NICE in Explanations for Medicare Drug Price Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— PCORI Engagement Award Letters of Intent Due April 1! See details below.
— Join PCORI's Advisory Panels: Applications, Nominations are Due this Friday, March 7! Click here for additional details and to submit an application.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.​

In this week's edition...
 
— CMS Collecting Written Information by March 1 and Holding Public Engagement Events for Medicare Drug Negotiation Program. See details below.
— Proposed Use of QALYs and Similar Measures from Foreign Countries. See details below.
— The Protecting Health Care for All Patients Act Has No Budget Impact. See details below.
— CMS References ICER and NICE in Explanations for Medicare Drug Price Negotiation Program. See details below.
— Join PCORI's Advisory Panels: Applications, Nominations are Due March 7! Click here for additional details and to submit an application.
— PIPC Calls for Robust Engagement and Transparency as CMS Reviews 15 Additional Drugs under Medicare Drug Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— Proposed Use of QALYs and Similar Measures from Foreign Countries in States - MD, OR and CO. See details below.
— The Protecting Health Care for All Patients Act Has No Budget Impact. See details below.
— CMS References ICER and NICE in Explanations for Medicare Drug Price Negotiation Program. See details below.
— Join PCORI's Advisory Panels: Applications, Nominations are Due March 7! Click here for additional details and to submit an application.
— PIPC Calls for Robust Engagement and Transparency as CMS Reviews 15 Additional Drugs under Medicare Drug Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— Center for Innovation Interviews Advocate Gwen Darian on Financial Equity. Click here to read the interview.
— Bonnell Foundation: Interview with CF United on PDABs, Etc. Click here to listen to the podcast.
— Join PCORI's Advisory Panels: Applications, Nominations are Due March 7! Click here for additional details and to submit an application.
— PIPC Calls for Robust Engagement and Transparency as CMS Reviews 15 Additional Drugs under Medicare Drug Negotiation Program. See details below.
— CMS References ICER and NICE in Explanations for Medicare Drug Price Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Lurie Institute for Disability Policy Introduces Toolkit. See details below.
— Center for Innovation & Value Research Seeking Stakeholder Interviews on Digital Health Therapies. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

— Bonnell Foundation: Interview with CF United on PDABS, Etc. Click here to listen to the podcast.
— Center for Innovation Interviews Advocate Gwen Darian on Financial Equity. Click here to read the interview.
— Join PCORI's Advisory Panels: Applications, Nominations are Due March 7! Click here for additional details and to submit an application.
— PIPC Calls for Robust Engagement and Transparency as CMS Reviews 15 Additional Drugs under Medicare Drug Negotiation Program. See details below.
— CMS References ICER and NICE in Explanations for Medicare Drug Price Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— CMS Leaders Discuss Efforts to Address Coverage and Access to Care. Click here to read the article. 
— Center for Innovation & Value Research Seeking Stakeholder Interviews on Digital Health Therapies. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below

In this week's edition...
 
— PIPC Calls for Robust Engagement and Transparency as CMS Reviews 15 Additional Drugs under Medicare Drug Negotiation Program. See details below.
— CMS References ICER and NICE in Explanations for Medicare Drug Price Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— CMS Leaders Discuss Efforts to Address Coverage and Access to Care. Click here to read the article. 
— Center for Innovation & Value Research Seeking Stakeholder Interviews on Digital Health Therapies. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

For Immediate Release
January 17, 2025 

Today, the Partnership to Improve Patient Care (PIPC) issued a statement on the selection of drugs subject to Medicare price negotiations in 2027.

In this week's edition...
 
— CMS References ICER and NICE in Explanations for Medicare Drug Price Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— CMS Leaders Discuss Efforts to Address Coverage and Access to Care. Click here to read the article. 
— New PCORI/AHRQ Research Shows Better Ways To Help Young People With OCD. Click here to read additional details on the review.
— New PCORI Funding Announcements Are Now Open! Click here for additional details.
— Center for Innovation & Value Research Seeking Stakeholder Interviews on Digital Health Therapies. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— CMS References ICER and NICE in Explanations for Medicare Drug Price Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— New PCORI/AHRQ Research Shows Better Ways To Help Young People With OCD. Click here to read additional details on the review.
— New PCORI Funding Announcements Are Now Open! Click here for additional details.
— Center for Innovation & Value Research Seeking Stakeholder Interviews on Digital Health Therapies. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— H.R. 485, the Protecting Health Care for All Patients Act, Has No Budget Impact. See details below.
— National Alliance for Caregiving Report Highlights Critical Need to Support Transplant Caregivers. See details below.
— New PCORI Funding Announcements Are Now Open! Click here for additional details.
— Center for Innovation & Value Research Seeking Stakeholder Interviews on Digital Health Therapies. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— H.R. 485, the Protecting Health Care for All Patients Act, Has No Budget Impact. See details below.
— Michigan Advocates Push for RDAC. See details below.
— New PCORI Funding Announcements Open Tomorrow! Click here for additional details.
— Center for Innovation & Value Research Seeking Stakeholder Interviews on Digital Health Therapies. See details below.
— Journal: Improving Access to Gene Therapies. Click here to read the article.
— National Alliance for Caregiving Report Highlights Critical Need to Support Transplant Caregivers. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— H.R. 485, the Protecting Health Care for All Patients Act, Has No Budget Impact. See details below.
— Center for Innovation & Value Research Seeking Stakeholder Interviews on Digital Health Therapies. See details below. 
— Journal: Improving Access to Gene Therapies. Click here to read the article.
— National Alliance for Caregiving Report Highlights Critical Need to Support Transplant Caregivers. See details below.
— Help Shape the NIH Strategic Plan for Disability Research. See details below.
— CMS Publishes Final Guidance for 2026-2027 Implementation of Negotiation Program. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.